Regarding the TILs, increased infiltration of FoxP3+ Tregs was associated with improved OS in colorectal, head and neck, and esophageal cancer, whereas in melanoma, lung, cervical, renal, hepatocellular, gastric, and breast cancers, it was linked with shorter OS [27]. Here, FOXP3 is linked to esophageal cancer.